• Pharmaceutical Packaging Market Share & Growth Report 2035

    Here is a structured Pharmaceutical Packaging Market analysis with company references and numerical values:

    📦 Pharmaceutical Packaging Market Overview
    Market size: USD 139.9 billion (2026) → USD 327.2 billion (2036)
    CAGR: ~8.8% (2026–2036)
    https://www.thebrainyinsights.com/report/pharmaceutical-packaging-market-12579

    🔹 Recent Developments (with company references)
    Amcor plc investing in recyclable and high-barrier packaging solutions to meet sustainability goals.
    Gerresheimer AG expanding drug delivery systems (prefilled syringes, vials); targeting ~20% EBITDA margins (2025 outlook).
    Schott AG focusing on high-quality glass vials for biologics and vaccines.
    West Pharmaceutical Services Inc. advancing containment and delivery systems for injectables.
    Adoption of RFID-enabled and smart packaging for tracking and anti-counterfeiting
    🚀 Drivers (with values & examples)
    Rising pharmaceutical production & exports
    India market growing at ~9.8% CAGR (2025–2031)
    Stringent regulatory requirements (serialization, tamper-proofing)
    Growing chronic disease burden & aging population
    Demand for sterile & biologics packaging
    Example: Becton Dickinson & Company expanding injectable packaging solutions
    ⛔ Restraints
    High cost of advanced materials (bioplastics, barrier polymers)
    Complex regulatory compliance across regions
    Supply chain disruptions affecting raw materials
    Example: Gerresheimer AG reported 0–2% growth slowdown (2025) due to weak demand in some segments
    🌍 Regional Segmentation Analysis
    North America
    ~39% market share (2024)
    Driven by advanced healthcare infrastructure
    Europe
    Strong regulatory compliance & innovation
    Asia-Pacific
    Fastest-growing region (China CAGR ~10.8%)
    Growth due to manufacturing expansion & exports
    India
    Rapid growth with strong domestic pharma production
    📈 Emerging Trends
    Smart packaging (RFID, QR tracking, serialization)
    Sustainable & recyclable packaging materials
    Rise of prefilled syringes & unit-dose packaging
    Growth in biologics & personalized medicine packaging
    Lightweight, high-barrier materials adoption
    💊 Top Use Cases
    Primary packaging (dominant ~67.5%) – vials, blister packs, bottles
    Biologics packaging – temperature-sensitive drugs
    Oral solid dosage packaging – ~45% share (tablets/capsules)
    Injectables & sterile packaging systems
    E-pharmacy & home delivery packaging solutions
    ⚠️ Major Challenges
    Counterfeit drugs → need for anti-counterfeit tech
    Cold-chain packaging complexity for biologics
    Environmental concerns over plastic waste
    High R&D cost for innovative packaging
    💡 Attractive Opportunities
    Growth in biopharmaceutical packaging (CAGR ~9%)
    Expansion of contract packaging organizations (CAGR ~9.8%)
    Eco-friendly materials (bioplastics, recyclable polymers)
    Digital packaging (smart labels, connected devices)
    Emerging markets (India, China, Southeast Asia)
    📊 Key Factors of Market Expansion
    Increasing global drug demand
    Technological innovation in packaging
    Strong regulatory push for safety
    Expansion of biologics & specialty drugs
    Growth of healthcare infrastructure globally
    🏢 Key Companies (with positioning)
    Amcor plc – sustainable flexible packaging leader
    Gerresheimer AG – glass & drug delivery systems
    West Pharmaceutical Services Inc. – injectable packaging leader
    Schott AG – specialty glass packaging
    AptarGroup Inc. – drug delivery & dispensing systems
    CCL Industries Inc. – labeling & packaging solutions
    http://brainyinsights.com/
    Pharmaceutical Packaging Market Share & Growth Report 2035 Here is a structured Pharmaceutical Packaging Market analysis with company references and numerical values: 📦 Pharmaceutical Packaging Market Overview Market size: USD 139.9 billion (2026) → USD 327.2 billion (2036) CAGR: ~8.8% (2026–2036) https://www.thebrainyinsights.com/report/pharmaceutical-packaging-market-12579 🔹 Recent Developments (with company references) Amcor plc investing in recyclable and high-barrier packaging solutions to meet sustainability goals. Gerresheimer AG expanding drug delivery systems (prefilled syringes, vials); targeting ~20% EBITDA margins (2025 outlook). Schott AG focusing on high-quality glass vials for biologics and vaccines. West Pharmaceutical Services Inc. advancing containment and delivery systems for injectables. Adoption of RFID-enabled and smart packaging for tracking and anti-counterfeiting 🚀 Drivers (with values & examples) Rising pharmaceutical production & exports India market growing at ~9.8% CAGR (2025–2031) Stringent regulatory requirements (serialization, tamper-proofing) Growing chronic disease burden & aging population Demand for sterile & biologics packaging Example: Becton Dickinson & Company expanding injectable packaging solutions ⛔ Restraints High cost of advanced materials (bioplastics, barrier polymers) Complex regulatory compliance across regions Supply chain disruptions affecting raw materials Example: Gerresheimer AG reported 0–2% growth slowdown (2025) due to weak demand in some segments 🌍 Regional Segmentation Analysis North America ~39% market share (2024) Driven by advanced healthcare infrastructure Europe Strong regulatory compliance & innovation Asia-Pacific Fastest-growing region (China CAGR ~10.8%) Growth due to manufacturing expansion & exports India Rapid growth with strong domestic pharma production 📈 Emerging Trends Smart packaging (RFID, QR tracking, serialization) Sustainable & recyclable packaging materials Rise of prefilled syringes & unit-dose packaging Growth in biologics & personalized medicine packaging Lightweight, high-barrier materials adoption 💊 Top Use Cases Primary packaging (dominant ~67.5%) – vials, blister packs, bottles Biologics packaging – temperature-sensitive drugs Oral solid dosage packaging – ~45% share (tablets/capsules) Injectables & sterile packaging systems E-pharmacy & home delivery packaging solutions ⚠️ Major Challenges Counterfeit drugs → need for anti-counterfeit tech Cold-chain packaging complexity for biologics Environmental concerns over plastic waste High R&D cost for innovative packaging 💡 Attractive Opportunities Growth in biopharmaceutical packaging (CAGR ~9%) Expansion of contract packaging organizations (CAGR ~9.8%) Eco-friendly materials (bioplastics, recyclable polymers) Digital packaging (smart labels, connected devices) Emerging markets (India, China, Southeast Asia) 📊 Key Factors of Market Expansion Increasing global drug demand Technological innovation in packaging Strong regulatory push for safety Expansion of biologics & specialty drugs Growth of healthcare infrastructure globally 🏢 Key Companies (with positioning) Amcor plc – sustainable flexible packaging leader Gerresheimer AG – glass & drug delivery systems West Pharmaceutical Services Inc. – injectable packaging leader Schott AG – specialty glass packaging AptarGroup Inc. – drug delivery & dispensing systems CCL Industries Inc. – labeling & packaging solutions http://brainyinsights.com/
    Pharmaceutical Packaging Market Size | Forecast, 2033 | The Brainy Insights
    The global pharmaceutical packaging market is anticipated to grow from USD 137.80 billion in 2023 to USD 289.34 billion by 2033, at a CAGR of 7.7% during the forecast period 2024-2033.
    0 التعليقات 0 المشاركات 139 مشاهدة 0 معاينة
  • AVG Logistics, a multimodal logistics solutions provider, reported a decline in its net profit by 5.51% at ₹5.08 crore in the second quarter of the fiscal year (Q2 FY26) as against ₹5.37 crore during the previous quarter ended September 2024.

    #AVGLogistics #logistics #supplychain #EBITDA
    AVG Logistics, a multimodal logistics solutions provider, reported a decline in its net profit by 5.51% at ₹5.08 crore in the second quarter of the fiscal year (Q2 FY26) as against ₹5.37 crore during the previous quarter ended September 2024. #AVGLogistics #logistics #supplychain #EBITDA
    WWW.ITLN.IN
    AVG Logistics net profit drops by 5%; maintains strong EBITDA
    Despite a marginal decline in net profit, the company maintained business momentum with revenue growth and improved operational efficiency.
    0 التعليقات 0 المشاركات 197 مشاهدة 0 معاينة
  • APSEZ plans to have a policy of average net debt to EBITDA of 2.5x in times to come, with cash generation prioritised for organic growth and strategic mergers and acquisitions (M&A).

    #Adaniports #APSEZ #shipping #cargo #EBITDA #strategicmergers #organicgrowth
    APSEZ plans to have a policy of average net debt to EBITDA of 2.5x in times to come, with cash generation prioritised for organic growth and strategic mergers and acquisitions (M&A). #Adaniports #APSEZ #shipping #cargo #EBITDA #strategicmergers #organicgrowth
    WWW.ITLN.IN
    Adani Ports to cap net debt at 2.5x of EBITDA
    APSEZ expects higher domestic growth, exceeding the projected 5.5–6% global trade growth, driven by new container capacity at Mundra next year.
    0 التعليقات 0 المشاركات 365 مشاهدة 0 معاينة
  • Adani Ports and Special Economic Zone (APSEZ), India’s largest port operator and developer, reported a 29% year-on-year (YoY) increase in net profit, reaching ₹3,120 crore for the quarter ended September 30, 2025, up from ₹2,413 crore in the corresponding period last year.

    #Adaniports #APSEZ #India #cargo #EBITDA #Shipping
    Adani Ports and Special Economic Zone (APSEZ), India’s largest port operator and developer, reported a 29% year-on-year (YoY) increase in net profit, reaching ₹3,120 crore for the quarter ended September 30, 2025, up from ₹2,413 crore in the corresponding period last year. #Adaniports #APSEZ #India #cargo #EBITDA #Shipping
    WWW.ITLN.IN
    Adani Ports net profit jumps 29% for Q2, revenue up 30%
    APSEZ revenue for FY26 is expected to be ₹36k - ₹38k cr and EBITDA is projected to be in the range of ₹21k - ₹22k cr.
    0 التعليقات 0 المشاركات 182 مشاهدة 0 معاينة
  • Mahindra Logistics on 27 October reported a net loss of ₹10.35 crore, compared to a net loss of ₹10.75 crore during the quarter ended September 2024 down by 3%.

    #MahindraLogistics #Q2 #quarterresults #EBITDA #Logistics
    Mahindra Logistics on 27 October reported a net loss of ₹10.35 crore, compared to a net loss of ₹10.75 crore during the quarter ended September 2024 down by 3%. #MahindraLogistics #Q2 #quarterresults #EBITDA #Logistics
    WWW.ITLN.IN
    Mahindra Logistics Q2 net loss narrows to ₹10.35 cr, revenue up by 11%
    EBITDA saw a 29% jump to ₹85 crore from ₹66 crore in the corresponding quarter of the previous fiscal.
    0 التعليقات 0 المشاركات 245 مشاهدة 0 معاينة
  • Allcargo Terminals Limited announced its financial results for the quarter ended June 30, 2025, reporting revenue of ₹187 crore, EBITDA of ₹35 crore and profit after tax of ₹9 crore. Compared to Q1FY25, revenue declined 1%, EBITDA rose 15% and PAT fell 5%.

    #AllcargoTerminals #Q1FY26 #NhavaSheva #Mundra #Chennai #Kolkata #Logistics
    Allcargo Terminals Limited announced its financial results for the quarter ended June 30, 2025, reporting revenue of ₹187 crore, EBITDA of ₹35 crore and profit after tax of ₹9 crore. Compared to Q1FY25, revenue declined 1%, EBITDA rose 15% and PAT fell 5%. #AllcargoTerminals #Q1FY26 #NhavaSheva #Mundra #Chennai #Kolkata #Logistics
    WWW.ITLN.IN
    Allcargo Terminals Q1FY26 EBITDA rises 15% year-on-year
    The company runs facilities at Nhava Sheva JNPT, Mundra, Chennai and Kolkata.
    0 التعليقات 0 المشاركات 610 مشاهدة 0 معاينة
  • Allcargo Gati has reported an 18% quarter-on-quarter jump in EBITDA for Q1FY26, reaching ₹14 crore. The performance comes despite a 7% dip in revenue compared to the previous quarter.

    #AllcargoGati #EBITDA #Q1FY26 #Logistics
    Allcargo Gati has reported an 18% quarter-on-quarter jump in EBITDA for Q1FY26, reaching ₹14 crore. The performance comes despite a 7% dip in revenue compared to the previous quarter. #AllcargoGati #EBITDA #Q1FY26 #Logistics
    WWW.ITLN.IN
    Allcargo Gati reports ₹14 cr EBITDA in Q1FY26; revenue at ₹357 cr
    The company’s EBITDA margin improved by 116 basis points over Q4FY25, while gross margin rose by 171 basis points sequentially.
    0 التعليقات 0 المشاركات 396 مشاهدة 0 معاينة
  • Maersk reported an eight percent revenue growth to $13.3 billion with EBIT increasing to $1.3 billion for the first quarter of 2025 from $177 million in 2024.

    #Maersk #RedSea #revenuegrowth #EBIT #EBITDA #shipping #supplychains
    Maersk reported an eight percent revenue growth to $13.3 billion with EBIT increasing to $1.3 billion for the first quarter of 2025 from $177 million in 2024. #Maersk #RedSea #revenuegrowth #EBIT #EBITDA #shipping #supplychains
    WWW.ITLN.IN
    Maersk maintains 2025 outlook, Q1 EBIT zooms to $1.3bn
    Ocean saw improved profitability to an EBIT of $743 million due to higher rates and stable volumes.
    0 التعليقات 0 المشاركات 384 مشاهدة 0 معاينة
  • Maersk reported an eight percent revenue growth to $13.3 billion with EBIT increasing to $1.3 billion for the first quarter of 2025 from $177 million in 2024.

    #Maersk #RedSea #revenuegrowth #EBIT #EBITDA #shipping #supplychains
    Maersk reported an eight percent revenue growth to $13.3 billion with EBIT increasing to $1.3 billion for the first quarter of 2025 from $177 million in 2024. #Maersk #RedSea #revenuegrowth #EBIT #EBITDA #shipping #supplychains
    WWW.LOGUPDATEAFRICA.COM
    Maersk Q1 EBIT zooms to $1.3bn, maintains 2025 outlook
    Maersk has maintained its 2025 guidance of underlying EBITDA of $6-9 billion and underlying EBIT of $0-3 billion.
    0 التعليقات 0 المشاركات 352 مشاهدة 0 معاينة